Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghobrial

Showing results (251-260 of 532) with videos related to

Pageof 54
Sort By:
Cell Death & Disease|June 30, 2026
Genetically modulating the RNA-binding protein Regnase-1 reveals its critical role in regulatory T cell homeostasis and function in vivoXiaojun Su, Xiang Xiao, Ge Deng, et al.
American Journal of Hematology|January 23, 2016
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemiaIrene M Ghobrial, David S Siegel, Ravi Vij, et al.
Blood|June 4, 2010
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaoying Jia, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2006
Long-term analysis of combined liver and kidney transplantation at a single centerRichard Ruiz, Hiroko Kunitake, Alan H Wilkinson, et al.
Cancer Research|March 15, 2015
Metabolic signature identifies novel targets for drug resistance in multiple myelomaPatricia Maiso, Daisy Huynh, Michele Moschetta, et al.
Transplantation Proceedings|May 28, 2005
Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scanD Liu, X-D Shen, Z Fang, et al.
Transplantation Proceedings|April 6, 2005
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejectionN V Semiletova, X D Shen, S J Slomowitz, et al.
Academic Radiology|December 17, 2013
Cine MR enterography grading of small bowel peristalsis: evaluation of the antiperistaltic effectiveness of sublingual hyoscyamine sulfatePeter M Ghobrial, Ilana Neuberger, Flavius F Guglielmo, et al.
Frontiers in Oncology|June 20, 2022
Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution ExperienceMaen Abdelrahim, Abdullah Esmail, Jiaqiong Xu, et al.
Pageof 54

Showing results (251-260 of 532) with videos related to

Sort By:
Pageof 54
Cell Death & Disease|June 30, 2026
Genetically modulating the RNA-binding protein Regnase-1 reveals its critical role in regulatory T cell homeostasis and function in vivoXiaojun Su, Xiang Xiao, Ge Deng, et al.
American Journal of Hematology|January 23, 2016
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemiaIrene M Ghobrial, David S Siegel, Ravi Vij, et al.
Blood|June 4, 2010
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaoying Jia, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2006
Long-term analysis of combined liver and kidney transplantation at a single centerRichard Ruiz, Hiroko Kunitake, Alan H Wilkinson, et al.
Cancer Research|March 15, 2015
Metabolic signature identifies novel targets for drug resistance in multiple myelomaPatricia Maiso, Daisy Huynh, Michele Moschetta, et al.
Transplantation Proceedings|May 28, 2005
Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scanD Liu, X-D Shen, Z Fang, et al.
Transplantation Proceedings|April 6, 2005
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejectionN V Semiletova, X D Shen, S J Slomowitz, et al.
Academic Radiology|December 17, 2013
Cine MR enterography grading of small bowel peristalsis: evaluation of the antiperistaltic effectiveness of sublingual hyoscyamine sulfatePeter M Ghobrial, Ilana Neuberger, Flavius F Guglielmo, et al.
Frontiers in Oncology|June 20, 2022
Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution ExperienceMaen Abdelrahim, Abdullah Esmail, Jiaqiong Xu, et al.
Pageof 54